Approves filing of scheme of merger of Auro Vaccines with Curateq Biologics
The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger of Auro Vaccines, a wholly owned step-down subsidiary of the Company with Curateq Biologics, a wholly owned subsidiary of the Company, with Hon’ble NCLT, Hyderabad.
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Feb 09 2026 | 7:51 PM IST
